chronic pelvic pain. Pelvic and perineal pain
Conditions
Interventions
Intervention 1: Intervention group: They will receive pelvic floor exercises with Surface EMG biofeedback for 10 sessions (up to one and a half months), simultaneously with the biofeedback sessions, t
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Age greater than or equal to 18 years Suffering from chronic pelvic pain (any pain that lasts more than 6 months and is in the area below the navel to the gluteal fold and causes functional problems for the patient) Presence of at least one painful muscle point in the pelvic area (below the navel to the gluteal fold) Age less than 60 years
Exclusion criteria
Exclusion criteria: Performing other conservative treatments during the study (oral medicine, manual therapy, physiotherapy, osteopathy, chiropractic, massage) People undergoing chemotherapy or radiotherapy in the pelvic Existence of oncological disease pregnancy pelvic surgery in the last 6 months Suffering from fibromyalgia or chronic fatigue Suffering from serious mental disorders The presence of excessive sensitivity in the skin that may interfere with the treatment process. Suffering from neuromuscular diseases Diabetic people
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain will be checked according to the VAS score. This quantitative and subjective variable includes marking the degree of pain intensity in a straight horizontal line with a constant length of 10 cm. The extremes are defined as extreme limits of a parameter measured from left (worst) to right (best). Timepoint: The beginning of the study (before the start of the intervention), the end of 10 treatment sessions, 3 and 6 months after the end of the treatment. Method of measurement: Visual Analog Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Average quality of life score. Timepoint: Before starting the treatment, after 10 treatment sessions, 3 months after the end of the treatment. Method of measurement: Short Form Health (SF-12).;Average score of fear of movement. Timepoint: Before starting the treatment, after 10 treatment sessions, 3 months after the end of the treatment. Method of measurement: Tampa Scale of Kinesiophobia (a questionnaire designed to evaluate the fear of movement from different dimensions (belief in injury, avoidance of activity). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactTannaz Ahadi
Iran University of Medical Sciences
Outcome results
None listed